Clinical trial
Ursodiol-Methotrexate for Primary Biliary Cirrhosis
NCT00006168 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ursodiol-Methotrexate for Primary Biliary Cirrhosis
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 1994
- Completion date
- March 31, 2004
- Enrollment
- Not reported
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.